A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Right to Contraception Act (S. 1999/H.R.4121) To amend the Internal Revenue Code of 1986 to provide a refundable personal credit for individuals who have suffered a stillbirth, and for other purposes. Expressing the sense of the Senate that the scientific judgment of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time sensitive medication abortion care in the United States should be equitable and based on science. (S.Res. 510) Abortion Care Capacity Enhancement and Support Services Act (not yet introduced) Womens Health Protection Act (S. 701/H.R. 12) The Equal Access to Abortion Coverage (EACH) Act (S. 1031/H.R. 561)

Client expense: $261,405 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for reproductive rights in the following legislation and government actions: H.R.12/S.701, Womens Health Protection Act of 2023  H.R. 5008/S. 2646, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R.2670, National Defense Authorization Act for Fiscal Year 2024, provision that includes contraception without co-pay provision for servicemembers and their dependents (section 707) H.R. 6298/S.3247, Stop Shackling and Detaining Pregnant Women Act H.R. 6357, Access to Reproductive Care for Servicemembers Act H.R. 6004/ S.3090, Maximizing Outcomes for Moms through Medicaid Improvement and Enhancement of Services (MOMMIES) Act H.R. 6103/S. 3137, Support through Loss Act S. RES. 510, a resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science Supporting efforts to protect nationwide access to mifepristone in light of the Alliance for Hippocratic Medicine v. FDA case. Expressing deep concerns with all the provisions in: S. 317, Reproductive Freedom for All Act Opposing all the provisions in: H.R. 6914, Pregnant Students' Rights Act

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordability is Access Act HR 3589/S 1698 Right to Contraception Act HR 4121/S 1999 Convenient Contraception Act HR 4816 / S 2427 S Res 510 - A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.

Client expense: $17,476 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE